Promote Tavo
19/01/2021 14:20
Jan 19 (Reuters) - OncoSec Medical Inc ONCS.O :
* ONCOSEC ENTERS INTO OPTION AGREEMENT WITH SIRTEX MEDICAL
TO
CO-PROMOTE TAVO™
* ONCOSEC MEDICAL - SIRTEX TO PAY $5 MILLION FOR A
NON-EXCLUSIVE
OPTION TO CO-PROMOTE TAVO
Source text for Eikon: ID:nPn2PT4Nra
Further company coverage: ONCS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OncoSec Medical Incorporated
See all newsBrief: OncoSec Medical Inc On June 15 Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Domino's, Aldeyra, MicroVision
Brief: OncoSec Medical Files Voluntary Petition For Relief Under Provisions Of Chapter 7 Of Title 11 Of United States Code
Brief: OncoSec Medical Terminates George Chi For Cause As Employee, CFO
Brief: Oncosec Medical Receives Non Compliance Notice From Nasdaq